This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Dalal AA, Stanford R, Corrao M, Pijuan P, Behar I, Chow R, Rubin J, Pandya A.Fluticasone furoate nasal spray has negligible impact on health plan budgets: output from a budget impact model. Journal of Allergy and Clinical Immunology 121 (Suppl. 2A): 195, Feb 2008
Kloepfer KM, Vargas PA, Jones SM, Helm ME.Preferred drug prescribing in Arkansas Medicaid: the use of less sedating antihistamines for the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology 121 (Suppl. 2A): 195, Feb 2008
Bonnet PO, Friedman HS, Li-McLeod JM.Rate of infections, costs and healthcare resource use in patients with undiagnosed primary immune deficiency. Journal of Allergy and Clinical Immunology 121 (Suppl. 2A): 69, Feb 2008
Kujawska A, Patel P, Walker A, Alame W, Toarmina P, Naar-King S, Ellis D, Secord E.Cost effectiveness of multi-systemic therapy for adherence in adolescents with high risk asthma. Journal of Allergy and Clinical Immunology 121 (Suppl. 2A): 41, Feb 2008
Mahesh PA, Parthasarathi G, Thomas S, Jayaraj BS, Vedanthan PK.Comparative pharmacoeconomic analysis of inhaled corticosteroids with salmeterol in steroid naive persistent asthma. Journal of Allergy and Clinical Immunology 121 (Suppl. 2A): 7, Feb 2008
Zazzali J, Solari PG, Chang E, Broder M.Assessment of healthcare utilization associated with integrated healthcare association's pay for performance asthma measure, appropriate use of rescue inhalers. Journal of Allergy and Clinical Immunology 121 (Suppl. 2A): 70, Feb 2008
Rights and permissions
About this article
Cite this article
News from AAAAI. Pharmacoecon. Outcomes News 550, 4–5 (2008). https://doi.org/10.2165/00151234-200805500-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805500-00007